Capstone Investment Advisors
LAB icon

Capstone Investment Advisors’s Standard BioTools LAB Stock Holding History

Capstone Investment Advisors’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-10,000
Closed -$294K – 476
2014
Q2 		$294K Buy
+10,000
New +$320K ﹤0.01% 370

Other funds holding LAB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capstone Investment Advisors's LAB Position: Q3 2014 in Review

Capstone Investment Advisors sold out of Standard BioTools (LAB) in Q3 2014, closing a stake of 10,000 shares — an estimated $294K sold.

Capstone Investment Advisors first reported a position in LAB in Q2 2014 and held it in 1 quarter. The position peaked at $294K in Q2 2014. 99 funds tracked by Wall St. Rank hold LAB as of Q3 2014.

  • Capstone Investment Advisors reported no remaining Standard BioTools position as of Q3 2014 after selling out during the quarter.
  • Capstone Investment Advisors sold 10,000 Standard BioTools shares in Q3 2014, an estimated $294K.
  • Capstone Investment Advisors first reported a position in Standard BioTools in Q2 2014 and held it in 1 quarter.
  • Capstone Investment Advisors's Standard BioTools position peaked at $294K in Q2 2014.
  • 99 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2014.

Based on Capstone Investment Advisors's 13F filing for Q3 2014, filed 14 Nov 2014.